化合物J27通过向JNK来缓解高脂肪饮食诱导的代谢功能障碍相关的脂肪性肝病

Jiaxi Ye1, Weiwei Zhu2, Yaqian Cui3

  • 1Department of Cardiology and Medical Research Center, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325000, China; Chemical Biology Research Center, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou 325035, Zhejiang, China.

概括

作为JNK抑制剂的J27通过在小鼠模型中减少肝脂肪,损伤和炎症,有效治疗与代谢功能障碍相关的脂肪性肝病 (MASLD). 这种化合物显示出作为MASLD的治疗方法的希望.